Pluriomics' Unattributed VC Round

Pluriomics raised a round of funding on March 30, 2017.

Pluriomics is a Belgian/Dutch biotechnology company whose mission is to deliver cardiac drug discovery and safety solutions based on its best-in-class human iPSC-derived cardiomyocyte technology. Spec…

Articles about Pluriomics' Unattributed VC Round: